Medical Advocates

HIV Infection/Disease
  HIV-Associated Castleman's Disease    

General Reports

Clinical Management

Drugs
Diagnostics
Epidemiology


 

 
 

HIV Oncology Main Page     Main New/Newsworthy                Home Page        

This web page is best viewed by using INTERNET EXPLORER
Last Update:  February 03, 2017

 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader

General Reports
 

     Journal Papers, Abstracts, and Commentaries
 
 

Relapse of multicentric Castleman's disease following Rituximab based therapy in HIV-positive patients.
Dalla Pria A, Pinato D, Roe J,
Blood. 2017 Jan 31.
Abstract

Short-term efficacy of the IL6 receptor antibody tocilizumab in patients with HIV-associated multicentric Castleman disease: report of two cases.
Nagao A, Nakazawa S, Hanabusa H.
J Hematol Oncol. 2014 Jan 17;7(1):10.
Relapse of multicentric Castleman's disease following Rituximab based therapy in HIV-positive patients.
Dalla Pria A, Pinato D, Roe J,
Blood. 2017 Jan 31.

Multicentric Castleman's disease and HIV.
Krause JR, Robinson SD, Vance EA.

Proc (Bayl Univ Med Cent)
. 2014 Jan;27(1):28-30.
Abstract

A case of multicentric Castleman's disease in HIV infection with the rare complication of acquired angioedema.
Fernando I, Scott G.
Int J STD AIDS
. 2013 Dec 18..
Abstract
 

Plasma-cell type Castleman's disease of the neck and lymphocyte-depletion Hodgkin lymphoma
associated with intestinal intussusception in an AIDS patient.
Lai CH, Tsai JW, Lin JN,  et al

J Microbiol Immunol Infect
. 2012 Apr 12. .

Abstract

Plasma-cell type Castleman's disease of the neck and lymphocyte-depletion Hodgkin lymphoma
associated with intestinal intussusception in an AIDS patient.
Lai CH, Tsai JW, Lin JN,  

J Microbiol Immunol Infect
. 2012 Apr 12. .
Abstract

Multicentric Castleman's disease as a cause for unclear febrile episodes in a 55-year-old
HIV-infected man.
Lederer H, Achermann Y, Tinguely M, et al
Infection. 2011 Aug 12.
Abstract

HIV-associated multicentric Castleman disease.
Reddy D, Mitsuyasu R.

Curr Opin Oncol. 2011 Jul 13.
Abstract


Clinical Management
 

      Journal Papers, Abstracts, and Commentaries
 
 
HIV-Associated Multicentric Castleman Disease Refractory to Antiretroviral Therapy: Clinical Features, Treatment and Outcome.
Alzahrani M, Hull MC, Sherlock C, et al  
Leuk Lymphoma
. 2014 Aug 5:1-22

Abstract

Drugs
 

Rituximab
 
     Videos
 
 
Dr. Uldrick on Rituximab Plus Liposomal Doxorubicin in HIV-Infected Patients With KSHV-MCD

 

      Journal Papers, Abstracts, and Commentaries
 
 
Brief communication: rituximab in HIV-associated multicentric Castleman disease.
Bower M, Powles T, Williams S, et al
Ann Intern Med. 2007 Dec 18;147(12):836-9.
Abstract
 
Vinblastine
 
      Journal Papers, Abstracts, and Commentaries
 
 
Vinblastine, rituximab and HAART, treatment of an HIV -positive patient with multicentric
Castleman's disease.
van Aalderen MC, Brinkman K, van den Berk GE, Terpstra WE.
Neth J Med
. 2010 Feb;68(2):87-90.
Abstract

Diagnostics
 

      Journal Papers, Abstracts, and Commentaries
 
 
18F-fluorodeoxyglucose positron emission tomography/computed tomography
findings in a patient with human immunodeficiency virus-associated
Castleman's disease and Kaposi sarcoma, disorders associated with
human herpes virus 8 infection.
Bertagna F, Biasiotto G, Rodella R,  et al

Jpn J Radiol
. 2010 Apr;28(3):231-4.
Abstract

Epidemiology
 

      Journal Papers, Abstracts, and Commentaries
 
 
Multicentric Castleman's disease & HIV infection.
Cotter A, Lambert J, O'Gorman P

Ir Med J. 2009 Oct;102(9):294-5.
Abstract


HIV Oncology Main Page  Main New/Newsworthy                Home Page        

 

HIV/-Associated Castleman's Disease